Pittsburgh -Topical tacrolimus ointment 0.1 percent (Protopic) may be a viable addition to the current therapeutic armamentarium for early-stage cutaneous T-cell lymphoma (CTCL), Larisa Geskin, M.D., said.
The Weekly Roundup: May 6-10
The Cutaneous Connection: A Reminder of Patient Impact
Climate-Related Factors Play A Role in The Incidence of Skin Cancer
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Inflammation May Play A Similar Role in Atopic Dermatitis, Psoriasis, And Major Depressive Disorder
AnaptysBio Announces Positive Topline Results from Phase 3 Trial of Imsidolimab for GPP